trending Market Intelligence /marketintelligence/en/news-insights/trending/sUpwNfCPF-idwg6DTCKG2A2 content esgSubNav
In This List

Madrigal Pharmaceuticals prices common stock offering

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Madrigal Pharmaceuticals prices common stock offering

Madrigal Pharmaceuticals Inc. priced an underwritten registered public offering of 1,506,025 common shares at $83 apiece.

The company expects gross proceeds of about $125 million.

Madrigal granted underwriters a 30-day option to buy up to an additional 225,904 common shares.

The offering is expected to close by Dec. 21, subject to customary closing conditions.

Goldman Sachs & Co. LLC is acting as lead book-running manager for the offering, with Evercore ISI acting as book runner. JMP Securities, Roth Capital Partners and H.C. Wainwright & Co. are acting as co-managers for the offering.